Catherine M. Bjerum

Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial

Catherine M. Bjerum, Allassane Ouattara, Aboulaye Meïté et al. · Clinical Infectious Diseases · 2019 · 58 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire

Constant Edi, Catherine M. Bjerum, Allassane Ouattara et al. · PLoS neglected tropical diseases · 2019 · 43 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

Moses Laman, Livingstone Tavul, Stephan Karl et al. · The Lancet Infectious Diseases · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

Livingstone Tavul, Moses Laman, Cade Howard et al. · PLoS neglected tropical diseases · 2022 · 26 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +14

Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases

Lucy N. John, Catherine M. Bjerum, Pere Millat-Martínez et al. · Clinical Infectious Diseases · 2020 · 12 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17